Kym White leads Edelman’s 600+ health specialists and provides communications counsel to a wide variety of healthcare clients.
Previously, Kym was the chief communications officer at Baxter International Inc. Prior to Baxter, Kym spent 16 years with Ogilvy PR Worldwide in a variety of roles including general manager of the New York office and co-managing director of the agency’s global healthcare practice.
Her experience includes 20+ years of work in corporate communications, healthcare product marketing and related issues management. She has developed and overseen U.S. and global communications programs for products at all stages of their lifecycle for many of the world’s leading pharmaceutical and biotechnology companies.
Kym has been recognized as one of the top 50 healthcare PR professionals by PRWeek. She was elected to the Arthur Page Society in 2008 and elevated to its Board of Trustees in 2009. She is a graduate of Northwestern University, with a B.S. in communications and political science.
Starting Monday, January 12th, nearly 5,000 healthcare company executives, analysts, institutional investors and assorted dealmakers will converge upon San Francisco to share their outlook for 2015 at the JP Morgan Healthcare Conference.
We are entering a new era in health that may not be fueled by blockbuster drugs for the masses, but one that will likely yield innovative therapies for our biggest health challenges, as well as well-placed optimism from investors and industry alike.
The leaders of Texas want to make it a state friendly for public-private partnerships, a destination for medical tourism and to attract innovators. But clearly, just as tort reform may deny remedies to people who need them most, a war for talent creates winners and losers.